136 related articles for article (PubMed ID: 31035658)
21. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
Ohrling K; Edler D; Hallström M; Ragnhammar P
Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
[TBL] [Abstract][Full Text] [Related]
22. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
24. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.
Dong YY; Xiang C; Lu JX; Su YX; Pan YF; Cai R; Zhang RJ; He ZK; Liu ML; Huang H; Bai X; Tang HY; Shi YH; Wang Y; Jiang W
Strahlenther Onkol; 2016 Jun; 192(6):394-402. PubMed ID: 27215563
[TBL] [Abstract][Full Text] [Related]
25. EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy.
Su NW; Leu YS; Lee JC; Liu CJ; Cheng CY; Lin JS; Chen YJ; Chen CK; Fang IC; Hsieh RK; Chang YF
Onco Targets Ther; 2014; 7():2197-204. PubMed ID: 25506224
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
Cao SM; Yang Q; Guo L; Mai HQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Qiu F; Sun R; Chen QY; Huang PY; Luo DH; Hua YJ; Wu YS; Lv X; Wang L; Xia WX; Tang LQ; Ye YF; Chen MY; Guo X; Hong MH
Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms in
Si W; Kang S; Sun H; Chen J; Cao S; Li Y
Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma.
Wu D; Chen X; Xu Y; Wang H; Yu G; Jiang L; Hong Q; Duan S
Oncol Lett; 2017 Apr; 13(4):2745-2750. PubMed ID: 28454461
[TBL] [Abstract][Full Text] [Related]
29. A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation-induced toxicities in esophageal cancer patients treated with definitive radiotherapy.
Chen Y; Zhu M; Zhang Z; Jiang G; Fu X; Fan M; Sun M; Wei Q; Zhao K
Cancer; 2013 Dec; 119(23):4205-11. PubMed ID: 24022861
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients.
Nogueira GAS; Costa EFD; Lopes-Aguiar L; Lima TRP; Visacri MB; Pincinato EC; Lourenço GJ; Calonga L; Mariano FV; Altemani AMAM; Altemani JMC; Moriel P; Chone CT; Ramos CD; Lima CSP
Oncotarget; 2018 Jul; 9(51):29538-29547. PubMed ID: 30038702
[TBL] [Abstract][Full Text] [Related]
31. Association of MLH1 single nucleotide polymorphisms with clinical outcomes of first-line irinotecan-based chemotherapy in colorectal cancer.
Wang D; Zhang X; Zhang Y; Wu Y; Guan X; Zhu W; Wang M; Qi C; Shen B
Onco Targets Ther; 2018; 11():8083-8088. PubMed ID: 30519050
[TBL] [Abstract][Full Text] [Related]
32. Single nucleotide polymorphisms in
Zhu X; Liu W; Qiu X; Wang Z; Tan C; Bei C; Qin L; Ren Y; Tan S
Oncotarget; 2017 Oct; 8(45):80039-80049. PubMed ID: 29108386
[TBL] [Abstract][Full Text] [Related]
33. Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score.
Yanamoto S; Otsuru M; Ota Y; Okura M; Aikawa T; Kurita H; Kamata T; Kirita T; Yamakawa N; Ueda M; Yamashita T; Komori T; Shigeta T; Yokoo S; Ogawa M; Umeda M;
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S992-9. PubMed ID: 26289809
[TBL] [Abstract][Full Text] [Related]
34. Mismatch repair-deficient status associates with favorable prognosis of Eastern Chinese population with sporadic colorectal cancer.
Gong Q; Zhang HH; Sun SB; Ge WM; Li Y; Zhu YC; Li LP
Oncol Lett; 2018 May; 15(5):7007-7013. PubMed ID: 29725427
[TBL] [Abstract][Full Text] [Related]
35. Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
Backes FJ; Haag J; Cosgrove CM; Suarez A; Cohn DE; Goodfellow PJ
Cancer; 2019 Feb; 125(3):398-405. PubMed ID: 30561762
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants in AKT1 gene were associated with risk and survival of OSCC in Chinese Han Population.
Wang Y; Lin L; Xu H; Li T; Zhou Y; Dan H; Jiang L; Liao G; Zhou M; Li L; Zeng X; Li J; Chen Q
J Oral Pathol Med; 2015 Jan; 44(1):45-50. PubMed ID: 25060489
[TBL] [Abstract][Full Text] [Related]
37. Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy.
Korpics MC; Block AM; Martin B; Hentz C; Gaynor ER; Henry E; Harkenrider MM; Solanki AA
Cancer; 2017 Sep; 123(18):3524-3531. PubMed ID: 28581675
[TBL] [Abstract][Full Text] [Related]
38. A Functional Polymorphism (rs10817938) in the XPA Promoter Region Is Associated with Poor Prognosis of Oral Squamous Cell Carcinoma in a Chinese Han Population.
Gao C; Wang J; Li C; Zhang W; Liu G
PLoS One; 2016; 11(9):e0160801. PubMed ID: 27622501
[TBL] [Abstract][Full Text] [Related]
39. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.
Mangoni M; Bisanzi S; Carozzi F; Sani C; Biti G; Livi L; Barletta E; Costantini AS; Gorini G
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):52-8. PubMed ID: 20708344
[TBL] [Abstract][Full Text] [Related]
40. PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population.
Yang XD; Zhao SF; Zhang Q; Li W; Wang YX; Hong XW; Hu QG
Tumour Biol; 2016 Jan; 37(1):577-82. PubMed ID: 26232326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]